Download Free Sample Report

Artificial Intelligence in Diabetes Management Market - Global Outlook and Forecast 2022-2028

Artificial Intelligence in Diabetes Management Market - Global Outlook and Forecast 2022-2028

  • Published on : 05 July 2022
  • Pages :68
  • Report Code:SMR-7184522

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of informationboth structured and unstructured datasuch as databases that have categorical variables, health records, and the scientific lexicon in research papers all of which is ingested and processed to make connections and then draw conclusions through a process of learning over time to increase in accuracy.
This report contains market size and forecasts of Artificial Intelligence in Diabetes Management in Global, including the following market information:

  • Global Artificial Intelligence in Diabetes Management Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)

The global Artificial Intelligence in Diabetes Management market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Case-based Reasoning Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence in Diabetes Management include Apple, Diabnext, Glooko, Google, IBM, Tidepool and Vodafone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artificial Intelligence in Diabetes Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence in Diabetes Management Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Diabetes Management Market Segment Percentages, by Type, 2021 (%)

  • Case-based Reasoning
  • Intelligent Data Analysis

Global Artificial Intelligence in Diabetes Management Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Diabetes Management Market Segment Percentages, by Application, 2021 (%)

  • Glucose Monitoring Devices
  • Diagnostic Devices
  • Insulin Delivery Devices
  • Other Devices

Global Artificial Intelligence in Diabetes Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Intelligence in Diabetes Management Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Artificial Intelligence in Diabetes Management revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Artificial Intelligence in Diabetes Management revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Apple
  • Diabnext
  • Glooko
  • Google
  • IBM
  • Tidepool
  • Vodafone